Depression Awareness Monthly
0
  • Home
  • Latest News
  • Depression
Depression Awareness Monthly
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression
Latest News

Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes

Doctorslounge
Posted by Doctorslounge
Share on
READ NEXT
Cases of Takotsubo Syndrome Up in Middle-Aged, Older Women

More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone

Read More

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Doctorslounge
Previous Article Men Face Five to Seven Times Higher Rates of Firearm Deaths Than Women
Next Article Final Exams Don’t Have to Be High Stress for Your Teen

ADVERTISEMENT

ADVERTISEMENT

You Might Also Enjoy

Latest News

School-Based Group Intervention Effective for Mental Health in Teen Girls

Latest News

Locally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure

Latest News

U.S. Life Expectancy Disadvantage Began in 1950s, Worsened Over Time

Latest News

ChatGPT Offers Evidence-Based Answers for Common Public Health Questions

Load More
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression

© 2020 - 2021 Powered by eHealthcare Solutions | Privacy Policy

×